Career history of Shubh Goel
Former positions of Shubh Goel
Companies | Position | Start | End |
---|---|---|---|
FENNEC PHARMACEUTICALS INC. | Corporate Officer/Principal | 2019-09-08 | 2022-02-27 |
CELGENE | Corporate Officer/Principal | 2012-12-31 | 2016-12-31 |
AVEO PHARMACEUTICALS, INC. | Sales & Marketing | 2010-12-31 | 2012-12-31 |
BAYER AG | Corporate Officer/Principal | 2006-12-31 | 2010-12-31 |
ODONATE, INC. | Chief Operating Officer | 2017-11-30 | 2018-11-18 |
Corporate Officer/Principal | 2018-11-18 | - |
Training of Shubh Goel
University of Bath | Undergraduate Degree |
Statistics
International
United States | 5 |
Germany | 2 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ODONATE, INC. | Health Technology |
BAYER AG | Health Technology |
FENNEC PHARMACEUTICALS INC. | Health Technology |
Private companies | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Shubh Goel
- Experience